Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythmsPRNewsWire • 09/08/26
Two Recessions Couldn't Stop These 4 Healthcare Stocks From Raising Dividends24/7 Wall Street • 08/31/26
How Abbott Labs Is Embracing RFK Jr.'s Make America Healthy Again MovementInvestors Business Daily • 08/31/26
Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formulaPRNewsWire • 08/31/26
The FDA Just Gave Abbott a Diabetes First. Is Its Beaten-Down Stock Ready to Wake Up?24/7 Wall Street • 08/27/26
Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of strokePRNewsWire • 08/27/26
FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patientsReuters • 08/25/26
Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetesPRNewsWire • 08/25/26
Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead.The Motley Fool • 08/24/26
Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infantsPRNewsWire • 08/20/26
Here's How Abbott's Medical Devices Arm Acts as a Growth CatalystZacks Investment Research • 08/19/26
Abbott Laboratories: Diagnostics And Medical Devices Fuel Next Growth Phase (Downgrade)Seeking Alpha • 08/19/26